about
Portal hypertension induced by congenital hepatic arterioportal fistula: report of four clinical cases and review of the literatureThe spleen in liver cirrhosis: revisiting an old enemy with novel targets.Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patientsAcute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data.Hemodynamic effects of renin-angiotensin-aldosterone inhibitor and β-blocker combination therapy vs. β-blocker monotherapy for portal hypertension in cirrhosis: A meta-analysisHigh-resolution Manometry Findings in Patients After Sclerotherapy for Esophageal Varices.Decompensated liver cirrhosis and neural regulation of mesenteric vascular tone in rats: role of sympathetic, nitrergic and sensory innervations.A Novel Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Increased Estimated Spleen/Graft Volume Ratio.Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis.Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.A conceptual and practical approach to haemostasis in paediatric liver disease.Evaluation of splenic perfusion and spleen size using dynamic computed tomography: Usefulness in assessing degree of liver fibrosis.Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms.Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.Biology of portal hypertension.Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.The portal hypertension syndrome: etiology, classification, relevance, and animal models.Intrahepatic angiogenesis increases portal hypertension in hepatitis B patients with cirrhosis.Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension
P2860
Q27024531-0CCF3E30-A36F-436A-80D9-4174CF4F09C7Q30355782-ADD41C4D-4A88-457A-BCD5-616EB032CD41Q35709044-1E2E0D01-ECCB-4C10-A083-E8D7E7681BBCQ35763952-5E74FD16-05C8-42D7-8E89-1A13D9DD7FA7Q36387949-16B2128B-CBAB-43FE-A392-D31965FD17BBQ36762631-64E84992-137B-4CCE-92B1-449D01F4846AQ37147861-CB28F88B-F0F8-4958-ACBB-C46E7768A72CQ37432592-FA103DB8-5BF0-409D-8280-73BD34C5AEE6Q38271966-CBFC5148-1460-4C75-969A-0AA63F9B566EQ38618343-84DACC9A-4FF5-44F9-BA2C-B152167084C5Q38788396-892E5DC5-54C0-4B6C-9EC7-C206148A866FQ40261026-C138D6FF-EBC9-48E9-8720-3AA504824E97Q47230773-E4CAC11F-B4E7-4F68-AAA8-5B9107517F5EQ47802250-85F21511-C911-421A-BC5B-C95372D54502Q47874043-9334D1CD-3F54-4AA7-B996-F2B2CDD49F72Q48155342-971D5E87-E1F8-4891-AFE7-B93426197516Q50075138-42975F5C-0BA8-4D94-90EA-FA1CA20F7E80Q50242973-138F243A-DF2D-4CB4-B7CD-B4E52A978F5EQ57815107-EB498EAA-EDE0-4103-800D-06742AB44E4A
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathophysiology of portal hypertension
@ast
Pathophysiology of portal hypertension
@en
Pathophysiology of portal hypertension
@nl
type
label
Pathophysiology of portal hypertension
@ast
Pathophysiology of portal hypertension
@en
Pathophysiology of portal hypertension
@nl
prefLabel
Pathophysiology of portal hypertension
@ast
Pathophysiology of portal hypertension
@en
Pathophysiology of portal hypertension
@nl
P2860
P3181
P1476
Pathophysiology of portal hypertension
@en
P2093
Yasuko Iwakiri
P2860
P304
P3181
P356
10.1016/J.CLD.2013.12.001
P407
P577
2014-02-25T00:00:00Z